Skip to main content
Contact Us
Subscribe
E-Edition
41°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BIIB
Recent news which mentions BIIB
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
31
32
Next >
Is Johnson & Johnson Setting a Dangerous Precedent for the Healthcare Industry?
March 26, 2022
Tickers
BIIB
JNJ
MRNA
OCGN
Tags
Recent Press Releases
BIIB
MRNA
From
Motley Fool
Why I Sold Kohl’s Corporation Despite Possible Buyout Deal
March 22, 2022
Tickers
BIIB
KSS
NLSN
Tags
NYSE:KSS,NYSE:NLSN,NASDAQ:BIIB
Market News
BIIB
From
InvestorPlace
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Health Care
BIIB
Biotech
From
Benzinga
2 Red Flags for Biogen's Future
March 22, 2022
Tickers
BIIB
LLY
Tags
Recent Press Releases
BIIB
LLY
From
Motley Fool
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
March 16, 2022
Tickers
BIIB
Tags
BIIB
Phase 3 Trial
Health Care
From
Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Biotech
Contracts
Alzheimer's disease
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
DTIL
RHHBY
GMDA
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
BIIB
General
RHHBY
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
March 08, 2022
Tickers
ACET
ACTD
ALEC
AREN
Tags
OXY
Intraday Update
EOG
From
Benzinga
10 Biggest Price Target Changes For Tuesday
March 08, 2022
Tickers
AUPH
AVDX
BBBY
BIIB
Tags
Price Target
BBBY
Pre/Market Outlook
From
Benzinga
As President Biden proposed, Medicare needs the ability to negotiate drug prices
March 07, 2022
Tickers
BIIB
Tags
BIIB
From
MarketWatch
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
March 04, 2022
Tickers
BIIB
CEMI
ESALY
EYEN
Tags
IBB
OCGN
Earnings
From
Benzinga
Why This Analyst Sees Roughly 20% Upside In This Large-Cap Biopharma
March 03, 2022
Tickers
BIIB
Tags
BIIB
RBC Capital Markets
Biotech
From
Benzinga
Expert Ratings For Biogen
March 03, 2022
Tickers
BIIB
Tags
Market News
Analyst Ratings
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
March 03, 2022
Tickers
ALGT
AORT
AVTX
BALY
Tags
KRC
ISEE
AORT
From
Benzinga
10 Biggest Price Target Changes For Thursday
March 03, 2022
Tickers
AEO
AI
BHG
BIIB
Tags
Human Resource & Employment Services
BIIB
SNOW
From
Benzinga
Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver
February 28, 2022
Tickers
BIIB
PFE
VTRS
Tags
PFE
BIIB
VTRS
From
MarketWatch
Medicare’s finances and the saga of the Alzheimer’s drug Aduhelm
February 24, 2022
Tickers
BIIB
Tags
BIIB
From
MarketWatch
What Investors Can Learn From Biogen's Drug Approval That No One Wants
February 23, 2022
Tickers
BIIB
Tags
BIIB
Recent Press Releases
Market News
From
Motley Fool
Could Advocacy Groups' Campaign for Aduhelm Benefit Biogen?
February 19, 2022
Tickers
BIIB
Tags
Market News
Recent Press Releases
BIIB
From
Motley Fool
Stocks That Hit 52-Week Lows On Thursday
February 17, 2022
Tickers
AFRM
AGNC
AHI
ALGS
Tags
SOND
Markets
MCHX
From
Benzinga
Sage Therapeutics - Biogen Partnered Depression Drug Meets Main Goal In Late-stage Study
February 16, 2022
Tickers
BIIB
SAGE
Tags
Phase 3 Trial
General
SAGE
From
Benzinga
US Senate Narrowly Votes In Favor Of Biden's Nominee Robert Califf To Lead FDA For Second Time
February 16, 2022
Tickers
BIIB
BNTX
PFE
Tags
Government
General
Briefs
From
Benzinga
3 Red Flags for Biogen's Future
February 16, 2022
Tickers
BIIB
Tags
Market News
Recent Press Releases
BIIB
From
Motley Fool
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
February 16, 2022
Tickers
ALKS
AMGN
ATXI
AVNS
Tags
BIIB
MRTX
CLPT
From
Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
February 16, 2022
Tickers
ARVN
BIIB
CCCC
GOOG
Tags
ARVN
RHHBY
GOOG
From
Motley Fool
What to Expect From Biogen's $2.3 Billion Shopping Spree
February 12, 2022
Tickers
AUPH
BHVN
BIIB
GS
Tags
BHVN
AUPH
Market News
From
Motley Fool
2 High-Yield Dividend Stocks That Are Trading Near Their 52-Week Lows
February 10, 2022
Tickers
AMGN
BIIB
GILD
MMM
Tags
RCUS
Recent Press Releases
BIIB
From
Motley Fool
2 Reasons to Buy Biogen, 1 Reason to Sell
February 10, 2022
Tickers
BIIB
Tags
Market News
BIIB
Recent Press Releases
From
Motley Fool
Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane
February 08, 2022
Tickers
BIIB
UCBJF
UCBJY
Tags
News
Contracts
Briefs
From
Benzinga
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.